TELIX Pharmaceuticals Ltd (TLX) — Cash Flow Quality Index
TELIX Pharmaceuticals Ltd (TLX) has a Cash Flow Quality Index of 3.04x as of June 2024. Operating cash flow of AU$35.45 Million exceeds net income of AU$11.68 Million, indicating high earnings quality where cash backs reported profits. Explore TELIX Pharmaceuticals Ltd (TLX) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
TELIX Pharmaceuticals Ltd Cash Flow Quality Index (2023–2024)
Historical Cash Flow Quality Index for TELIX Pharmaceuticals Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TELIX Pharmaceuticals Ltd (TLX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for TELIX Pharmaceuticals Ltd (2023–2024)
Year-by-year earnings quality comparison for TELIX Pharmaceuticals Ltd. For live market cap and the full company financial profile, see TELIX Pharmaceuticals Ltd (TLX) market capitalisation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | AU$43.03 Million | AU$49.92 Million | ▼ -81.2% |
| 2023 | 4.58x | AU$23.88 Million | AU$5.21 Million | — |